Landscape targeted of therapy in advanced pancreatic adenocarcinoma: a network meta-analysis of randomized controlled trials [2010–2024]
This NMA combining network and forest plot results showed that Gem-Nimot provided significant survival benefits in advanced PA. EGFR-targeted combinations demonstrated a significant advantage in both OS and PFS compared with gemcitabine alone, indicating that EGFR inhibition may provide real clinical benefits.
Authors
- Shihan Deng (ORCID: https://orcid.org/0000-0003-2232-5415)
- Sheng Wang (ORCID: https://orcid.org/0000-0003-1835-0458)
- Huixin Ma
- Yunjin Ya
- Yun Jin
Institutions
- Kunming University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/jgo-2025-452
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00